Real-world incidence and risk factors of bortezomib-related cardiovascular adverse events in patients with multiple myeloma
Crossref DOI link: https://doi.org/10.1007/s44313-024-00004-y
Published Online: 2024-02-19
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jang, Bitna
Jeong, Jonghyun
Heo, Kyu-Nam
Koh, Youngil
Lee, Ju‑Yeun
Text and Data Mining valid from 2024-02-19
Version of Record valid from 2024-02-19
Article History
Received: 17 October 2023
Accepted: 11 January 2024
First Online: 19 February 2024
Declarations
:
: The authors report there are no competing interests to declare.